Cargando…
Current status of drug screening and disease modelling in human pluripotent stem cells
The emphasis in human pluripotent stem cell (hPSC) technologies has shifted from cell therapy to in vitro disease modelling and drug screening. This review examines why this shift has occurred, and how current technological limitations might be overcome to fully realise the potential of hPSCs. Detai...
Autores principales: | Rajamohan, Divya, Matsa, Elena, Kalra, Spandan, Crutchley, James, Patel, Asha, George, Vinoj, Denning, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597971/ https://www.ncbi.nlm.nih.gov/pubmed/22886688 http://dx.doi.org/10.1002/bies.201200053 |
Ejemplares similares
-
Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Rajamohan, Divya, et al.
Publicado: (2016) -
Modeling heterogeneity in the pluripotent state: A promising strategy for improving the efficiency and fidelity of stem cell differentiation
por: Espinosa Angarica, Vladimir, et al.
Publicado: (2016) -
Innovation in biological microscopy: Current status and future directions
por: Swedlow, Jason R
Publicado: (2012) -
Cardiomyocytes from human pluripotent stem cells: From laboratory
curiosity to industrial biomedical platform()
por: Denning, Chris, et al.
Publicado: (2016) -
Organoids and the genetically encoded self‐assembly of embryonic stem cells
por: Turner, David A., et al.
Publicado: (2015)